{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:24Z","timestamp":1787032764043,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,20]]},"DOI":"10.7759\/cureus.45623","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T14:14:43Z","timestamp":1695219283000},"source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Fertilization Outcomes With a Dual Trigger in Normoresponders in Antagonist Cycles"],"prefix":"10.7759","author":[{"given":"Munire Funda","family":"Cevher Akdulum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u00e7il \u0130rem","family":"Ar\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Demirda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.12.054","article-title":"Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome","volume":"95","author":"Cerrillo M","year":"2011","unstructured":"Cerrillo M, Pacheco A, Rodr\u00edguez S, G\u00f3mez R, Delgado F, Pellicer A, Garcia-Velasco JA. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertil Steril. 2011, 95:2517-9. 10.1016\/j.fertnstert.2010.12.054","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008046.pub3","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles","author":"Youssef MA","year":"2014","unstructured":"Youssef MA, Van der Veen F, Al-Inany HG, et al.. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2014, CD008046. 10.1002\/14651858.CD008046.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen Y","year":"1990","unstructured":"Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990, 71:918-22. 10.1210\/jcem-71-4-918","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh613","article-title":"Can we eliminate severe ovarian hyperstimulation syndrome?","volume":"20","author":"Orvieto R","year":"2005","unstructured":"Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome?. Hum Reprod. 2005, 20:320-2. 10.1093\/humrep\/deh613","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019339","article-title":"Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications","volume":"11","author":"Kol S","year":"1996","unstructured":"Kol S, Lewit N, Itskovitz-Eldor J. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications. Hum Reprod. 1996, 11:1143-4. 10.1093\/oxfordjournals.humrep.a019339","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol S","year":"2004","unstructured":"Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril. 2004, 81:1-5. 10.1016\/j.fertnstert.2003.05.032","journal-title":"Fertil Steril"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan P","year":"2011","unstructured":"Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Hum Reprod Update. 2011, 17:510-24. 10.1093\/humupd\/dmr008","journal-title":"Hum Reprod Update"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan P","year":"2005","unstructured":"Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Gr\u00f8ndahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study. Hum Reprod. 2005, 20:1213-20. 10.1093\/humrep\/deh765","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2012.11.002","article-title":"GnRH agonist triggering: recent developments","volume":"26","author":"Kol S","year":"2013","unstructured":"Kol S, Humaidan P. GnRH agonist triggering: recent developments. Reprod Biomed Online. 2013, 26:226-30. 10.1016\/j.rbmo.2012.11.002","journal-title":"Reprod Biomed Online"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.02.003","article-title":"Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?","volume":"109","author":"Benadiva C","year":"2018","unstructured":"Benadiva C, Engmann L. Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?. Fertil Steril. 2018, 109:763-7. 10.1016\/j.fertnstert.2018.02.003","journal-title":"Fertil Steril"},{"key":"ref11","article-title":"Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization","volume":"59","author":"Kim CH","year":"2014","unstructured":"Kim CH, Ahn JW, You RM, Kim SH, Chae HD, Kang BM. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization. J Reprod Med. 2014, 59:63-8.","journal-title":"J Reprod Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.07.1976","article-title":"Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles","volume":"100","author":"Lin MH","year":"2013","unstructured":"Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013, 100:1296-302. 10.1016\/j.fertnstert.2013.07.1976","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101728","article-title":"Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: randomized controlled trial","volume":"49","author":"Ali SS","year":"2020","unstructured":"Ali SS, Elsenosy E, Sayed GH, et al.. Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: randomized controlled trial. J Gynecol Obstet Hum Reprod. 2020, 49:101728. 10.1016\/j.jogoh.2020.101728","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12457","article-title":"Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders","volume":"141","author":"Zhou X","year":"2018","unstructured":"Zhou X, Guo P, Chen X, Ye D, Liu Y, Chen S. Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders. Int J Gynaecol Obstet. 2018, 141:327-31. 10.1002\/ijgo.12457","journal-title":"Int J Gynaecol Obstet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.07.1316","article-title":"Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study","volume":"90","author":"Schachter M","year":"2008","unstructured":"Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil Steril. 2008, 90:1087-93. 10.1016\/j.fertnstert.2007.07.1316","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa107","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study","volume":"35","author":"Haas J","year":"2020","unstructured":"Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R, Casper RF. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod. 2020, 35:1648-54. 10.1093\/humrep\/deaa107","journal-title":"Hum Reprod"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683210","article-title":"Effect of a \u201cdual trigger\u201d using a GnRH agonist and hCG on the cumulative live-birth rate for normal responders in GnRH-antagonist cycles","volume":"8","author":"Gao F","year":"2021","unstructured":"Gao F, Wang Y, Fu M, Zhang Q, Ren Y, Shen H, Han H. Effect of a \u201cdual trigger\u201d using a GnRH agonist and hCG on the cumulative live-birth rate for normal responders in GnRH-antagonist cycles. Front Med (Lausanne). 2021, 8:683210. 10.3389\/fmed.2021.683210","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.6.1211","article-title":"Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists","volume":"15","author":"Hernandez ER","year":"2000","unstructured":"Hernandez ER. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod. 2000, 15:1211-6. 10.1093\/humrep\/15.6.1211","journal-title":"Hum Reprod"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod59.3.661","article-title":"Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle","volume":"59","author":"Raga F","year":"1998","unstructured":"Raga F, Casa\u00f1 EM, Kruessel JS, Wen Y, Huang HY, Nezhat C, Polan ML. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod. 1998, 59:661-9. 10.1095\/biolreprod59.3.661","journal-title":"Biol Reprod"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32834cd3b0","article-title":"Gonadotropin-releasing hormone\/gonadotropin-releasing hormone receptor signaling in the placenta","volume":"18","author":"Sasaki K","year":"2011","unstructured":"Sasaki K, Norwitz ER. Gonadotropin-releasing hormone\/gonadotropin-releasing hormone receptor signaling in the placenta. Curr Opin Endocrinol Diabetes Obes. 2011, 18:401-8. 10.1097\/MED.0b013e32834cd3b0","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/me.2008-0451","article-title":"Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways","volume":"23","author":"Liu J","year":"2009","unstructured":"Liu J, Maccalman CD, Wang YL, Leung PC. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways. Mol Endocrinol. 2009, 23:1014-21. 10.1210\/me.2008-0451","journal-title":"Mol Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1576621","article-title":"Does double trigger (GnRH-agonist\u2009+\u2009hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study","volume":"35","author":"Haas J","year":"2019","unstructured":"Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, Orvieto R. Does double trigger (GnRH-agonist\u2009+\u2009hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecol Endocrinol. 2019, 35:628-30. 10.1080\/09513590.2019.1576621","journal-title":"Gynecol Endocrinol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.09.002","article-title":"Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF\/ICSI cycles","volume":"35","author":"Zhang J","year":"2017","unstructured":"Zhang J, Wang Y, Mao X, et al.. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF\/ICSI cycles. Reprod Biomed Online. 2017, 35:701-7. 10.1016\/j.rbmo.2017.09.002","journal-title":"Reprod Biomed Online"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4751-3","article-title":"Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF\/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis","volume":"298","author":"Chen CH","year":"2018","unstructured":"Chen CH, Tzeng CR, Wang PH, Liu WM, Chang HY, Chen HH, Chen CH. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF\/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018, 298:17-26. 10.1007\/s00404-018-4751-3","journal-title":"Arch Gynecol Obstet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00766-5","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials","volume":"19","author":"Hu KL","year":"2021","unstructured":"Hu KL, Wang S, Ye X, Zhang D, Hunt S. GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials. Reprod Biol Endocrinol. 2021, 19:78. 10.1186\/s12958-021-00766-5","journal-title":"Reprod Biol Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20220035","article-title":"Dual trigger vs. conventional trigger outcomes in in vitro fertilization. Systematic review and meta-analysis","volume":"27","author":"Gonz\u00e1lez VG","year":"2023","unstructured":"Gonz\u00e1lez VG, Triana AM, Garc\u00eda IS, Nieto SO, Urrutia MC, Garc\u00eda IC, Gasta\u00f1aga-Holguera T. Dual trigger vs. conventional trigger outcomes in in vitro fertilization. Systematic review and meta-analysis. JBRA Assist Reprod. 2023, 27:112-9. 10.5935\/1518-0557.20220035","journal-title":"JBRA Assist Reprod"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187138-in-vitro-fertilization-outcomes-with-a-dual-trigger-in-normoresponders-in-antagonist-cycles","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:07:56Z","timestamp":1707491276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187138-in-vitro-fertilization-outcomes-with-a-dual-trigger-in-normoresponders-in-antagonist-cycles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.45623","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}